Short Interest in IMAX Corporation (NYSE:IMAX) Declines By 31.5%

30 Dec 2025, 03:18 by Danessa Lincoln · The Markets Daily

IMAX Corporation (NYSE:IMAX – Get Free Report) was the target of a large drop in short interest during the month of December. As of December 15th, there was short interest totaling 4,244,737 shares, a drop of 31.5% from the November 30th total of 6,193,774 shares. Based on an average daily trading volume, of 2,191,944 shares, the days-to-cover ratio is presently 1.9 days. Currently, 10.4% of the company’s stock are short sold. Currently, 10.4% of the company’s stock are short sold. Based on an average daily trading volume, of 2,191,944 shares, the days-to-cover ratio is presently 1.9 days.

IMAX Trading Down 0.5%

IMAX stock traded down $0.21 during mid-day trading on Monday, hitting $37.47. 774,235 shares of the company were exchanged, compared to its average volume of 1,710,393. IMAX has a 1-year low of $20.48 and a 1-year high of $39.98. The stock has a market capitalization of $2.02 billion, a PE ratio of 52.77, a price-to-earnings-growth ratio of 2.29 and a beta of 0.41. The business has a 50 day simple moving average of $35.58 and a 200-day simple moving average of $31.27.

IMAX (NYSE:IMAX – Get Free Report) last announced its earnings results on Thursday, October 23rd. The company reported $0.47 earnings per share for the quarter, topping analysts’ consensus estimates of $0.31 by $0.16. The company had revenue of $106.65 million for the quarter, compared to analyst estimates of $102.88 million. IMAX had a return on equity of 9.91% and a net margin of 10.47%.The firm’s quarterly revenue was up 16.6% compared to the same quarter last year. During the same quarter last year, the company earned $0.35 earnings per share. Equities research analysts expect that IMAX will post 0.91 earnings per share for the current year.

Insider Buying and Selling

In other IMAX news, EVP Giovanni M. Dolci sold 6,188 shares of the company’s stock in a transaction that occurred on Monday, November 10th. The stock was sold at an average price of $34.25, for a total transaction of $211,939.00. Following the completion of the transaction, the executive vice president owned 33,000 shares of the company’s stock, valued at $1,130,250. This represents a 15.79% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, VP Robert D. Lister sold 50,143 shares of the firm’s stock in a transaction that occurred on Friday, November 7th. The stock was sold at an average price of $34.67, for a total transaction of $1,738,457.81. Following the transaction, the vice president directly owned 161,421 shares of the company’s stock, valued at $5,596,466.07. This represents a 23.70% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 24.08% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On IMAX

A number of institutional investors have recently modified their holdings of the business. TD Waterhouse Canada Inc. increased its position in IMAX by 125.0% during the second quarter. TD Waterhouse Canada Inc. now owns 900 shares of the company’s stock worth $25,000 after acquiring an additional 500 shares during the period. CIBC Private Wealth Group LLC acquired a new position in shares of IMAX during the 3rd quarter worth approximately $27,000. First Horizon Corp bought a new position in shares of IMAX during the third quarter worth approximately $34,000. Jones Financial Companies Lllp increased its holdings in shares of IMAX by 43.8% during the third quarter. Jones Financial Companies Lllp now owns 1,041 shares of the company’s stock worth $34,000 after purchasing an additional 317 shares during the period. Finally, Clearstead Advisors LLC acquired a new stake in shares of IMAX in the third quarter valued at approximately $35,000. Institutional investors own 93.51% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently weighed in on the stock. Barrington Research raised their target price on shares of IMAX from $37.00 to $42.00 and gave the company an “outperform” rating in a research note on Monday, December 8th. B. Riley reiterated a “buy” rating on shares of IMAX in a research note on Monday, December 8th. The Goldman Sachs Group upgraded shares of IMAX from a “sell” rating to a “neutral” rating and boosted their price objective for the stock from $22.00 to $34.00 in a research note on Tuesday, November 25th. Benchmark raised their target price on shares of IMAX from $40.00 to $42.00 and gave the company a “buy” rating in a research note on Monday, December 8th. Finally, Wells Fargo & Company lifted their price target on IMAX from $40.00 to $47.00 and gave the stock an “overweight” rating in a report on Thursday, December 18th. Ten analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, IMAX has a consensus rating of “Moderate Buy” and a consensus price target of $41.50.

View Our Latest Stock Analysis on IMAX

IMAX Company Profile

(Get Free Report)

IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.